相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
Julie J. Paik et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report
Tsai-Hung Yen et al.
MEDICINA-LITHUANIA (2021)
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
Yuchuan Ding et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Dermatomyositis: Diagnosis and treatment
Reid Waldman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants
Dario Didona et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2020)
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease
Zhiwei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease
Sei-ichiro Motegi et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2019)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Ingrid E. Lundberg et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer
Toshifumi Yamaoka et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
分享论文
